Merck & Co.

Bio-Process Systems Alliance Elects Leadership Team for 2013-2015

Merck Steers Doctors Away from HDL Cholesterol Drug

Drug Industry Treading Water on R&D Productivity

Human Stool Treatment Upends Race to Treat Colon Germ

GSK and J&J Lead Rivals in Drug Access for Poor

Tax Gains Lift Merck & Co Q3 Profits

The European Pharmaceuticals Economy at Halftime 2012

Topics • Technology

Thriving Generics

Strong Merck & Co Results Boost Faith as Generics Loom

EU Agency Lifts Lid on Drug Data Secrets

Generics Seen Cutting into Drug Sales Growth through 2016

BlackRock, Merck Top-ranked among U.S. Corporate Boards

Drugmaker Amylin Draws Initial Bids

Roche Gives Up on Heart Drug after Trial Disappoints

U.S. Medicine Spending Rose to $320 Billion Last Year

Bayer Sounds Out Debt Market with Eye On Deals

Kenneth Frazier To Succeed Richard Clark as Merck & Co. Chair

Merck Sells 50% Interest in Johnson & Johnson

Merck Appoints Cuong Viet Do As Chief Strategy Officer

Richard DeLuca Named President, Merck Animal Health

Merck Q2 Profit Soars; 13% Job Reductions Planned by 2015

Merck Inks New Non-Exclusive Agreement With Roche

Merck Loses Bid To Recoup $473 Million In U.S.

Roche to Provide Tests for Merck Cancer Drugs

Topics • Technology

The World Of Biosimilars

Merck Reports Higher-Than-Expected Earnings

Merck & Co to Buy Back Up To $5 Billion Of Its Shares

Sun Pharma To Sell Some Merck Diabetes Drugs In India

Merck & Co. Commences Tender Offer for Inspire Pharmaceuticals

India's Sun Pharma, US Merck in Generics Joint Venture

Merck KGaA Eyes Job Cuts at Drugs Unit

Merck, Sun Pharma Eye India Marketing Tie-Up

Merck's Dutch R&D Unit To Keep Some Jobs, Change Focus

Merck To Acquire Inspire Pharma For $430 Million

Chris Viehbacher: Sanofi to Grow Animal Health Through Bolt-On Buys

32 more articles

Top-Feature

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Operationalizing AI in Polymer Development: How Syensqo Is Scaling Impact with the Citrine Platform

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Aenova Holding GmbH

Mastering Modified Release: The Pellet-Based Approach

Expert Insights

ADCs for Precision Cancer Therapy

Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.